Inventors
Stefan Moese, Nike Kräutler, Cédric Cortijo, Jan Grimm, Benoit Combaluzier, Roger Nitsch, Christoph Hock
Assignees
- Neurimmune Ag
Abstract
Provided are novel human-derived monoclonal antibodies as well as antigen-binding fragments thereof which specifically recognize and preferably neutralize severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The anti-SARS-CoV-2 antibodies provided herein are useful in treating and diagnosis of COVID-19.